RenovoRx, Inc.

Biotech Mountain View, CA

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
Biotech
Headquarters
Mountain View, CA
Street
2570 W El Camino Real, Suite 320
Zip
94040

Offering

Total offering
$10M
Amount sold
$10M
First sale
Mar 20, 2026
Min investment
$10k
Securities
Equity
Federal exemption
Rule 506(b)
Investors so far
16

How this filing compares

Ranked #11 of 47 Biotech filings in April 2026 by offering amount.

Median Biotech filing in April 2026: $3M. This offering is 3.3× the median.

Other California filings this week: A-Star Fund III, LP, Artie Technologies Inc., BAY HILLS CAPITAL PARTNERS VI-A, L.P., BAY HILLS CAPITAL PARTNERS VI, L.P., Cityview Real Estate Partners VIII, LP

Leadership

Shaun R. Bagai — Executive Officer (also: Director)

Mark Voll — Executive Officer

Leesa Gentry — Executive Officer

Ramtin Agah — Executive Officer

Laurence J. Marton — Director

Una S. Ryan — Director

Kirsten Angela Macfarlane — Director

Robert J. Spiegel — Director

Filing details

RenovoRx, Inc. filed a Form D with the SEC on April 9, 2026.

Other newest Biotech companies

Other newest companies in California